Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
The Ras Gene02:38

The Ras Gene

7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.0K
Skin Cancer01:30

Skin Cancer

5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Abnormal Proliferation02:23

Abnormal Proliferation

5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sweat gland carcinoma: a comprehensive review Part I: sweat gland carcinomas arising de novo.

Virchows Archiv : an international journal of pathology·2026
Same author

Using spaced repetition to teach histopathology significantly improves diagnostic skills: A randomized within-participant evaluation.

Anatomical sciences education·2026
Same author

The acinar variant of poroma: a series of 3 cases with YAP1::NR4A3 fusion.

Virchows Archiv : an international journal of pathology·2026
Same author

Primary cutaneous non neuroendocrine small cell carcinoma POU2F3 subtype: morphologic, immunohistochemical, transcriptomic and methylation analysis of two cases.

Virchows Archiv : an international journal of pathology·2026
Same author

Primary Cutaneous SWI/SNF-Deficient Carcinomas: Morphologic, Immunohistochemical, and Molecular Analysis of Seven Cases.

The American journal of surgical pathology·2026
Same author

Lack of YAP1 Expression in Endocrine Mucin-Producing Sweat Gland Carcinoma.

Journal of cutaneous pathology·2026
Same journal

TROP2 immunoreactivity in pulmonary large cell neuroendocrine carcinoma.

Histopathology·2026
Same journal

Malignant adenomyoepithelioma of the breast: seven cases illustrating morphological diversity and diagnostic challenges.

Histopathology·2026
Same journal

A CRX-positive RB1-deficient bone tumour with a retinoblastoma-like DNA methylation profile.

Histopathology·2026
Same journal

Perivascular epithelioid cell tumours of the genitourinary tract: clinicopathological features and molecular landscape.

Histopathology·2026
Same journal

Navigating diagnostic challenges in low-grade spindle cell lesions of the breast: a retrospective review.

Histopathology·2026
Same journal

Neoplastic transformation of sporadic gastric hyperplastic polyps: a systematic review and meta-analysis of risk factors and clinicopathological features.

Histopathology·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

Cell Population Analyses During Skin Carcinogenesis
06:53

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

12.9K

RB1 inactivation in cutaneous carcinomas.

Tiffany Liv1, Antoine Touzé1, David Schrama2

  • 1Équipe Biologie des Infections à Polyomavirus, UMR INRAE ISP 1282, Université de Tours, Tours, France.

Histopathology
|December 15, 2025
PubMed
Summary
This summary is machine-generated.

RB1 gene inactivation, crucial for cell cycle regulation, also impacts tumor cell characteristics. Its loss is key in Merkel cell carcinoma and other cancers, offering diagnostic and therapeutic potential.

Keywords:
Merkel cell carcinomaRB1Wnt/beta‐catenin non pilomatrical carcinomasebaceous carcinomasquamous cell carcinoma

More Related Videos

Inducible and Reversible Dominant-negative DN Protein Inhibition
08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.7K
Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

61.2K

Related Experiment Videos

Last Updated: Jan 8, 2026

Cell Population Analyses During Skin Carcinogenesis
06:53

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

12.9K
Inducible and Reversible Dominant-negative DN Protein Inhibition
08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.7K
Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

61.2K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The RB1 gene, encoding the retinoblastoma protein pRB, is a known tumor suppressor and cell cycle regulator.
  • pRB also plays a role in cell differentiation, restricting stem cell properties.
  • RB1 inactivation contributes to tumor progression and phenotypic changes.

Purpose of the Study:

  • To review the role of RB1 inactivation in oncogenesis and tumor cell phenotypes.
  • To summarize knowledge on RB1-deficient cutaneous carcinomas.
  • To highlight the diagnostic, prognostic, and therapeutic potential of RB1 pathway characterization.

Main Methods:

  • Literature review of RB1's function in cancer.
  • Analysis of RB1 alterations in various tumor types.
  • Focus on RB1-deficient cutaneous carcinomas, including Merkel cell carcinoma.

Main Results:

  • RB1 inactivation is found in 5% of human cancers, with higher prevalence in specific subtypes like retinoblastoma and small cell lung carcinoma.
  • RB1 loss is a hallmark of Merkel cell carcinoma and observed in other skin cancers.
  • RB1 inactivation influences both cell cycle control and tumor cell phenotype.

Conclusions:

  • RB1 inactivation significantly contributes to oncogenesis and tumor progression.
  • Understanding RB1 status in cutaneous carcinomas is vital for diagnosis and prognosis.
  • Targeting the RB1 pathway may offer therapeutic strategies for RB1-deficient tumors.